# DOXORUBICIN HYDROCHLORIDE
> **ANDA206062** · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2019-05-13
## Drug
- **FDA Application Number:** ANDA206062
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXORUBICIN HYDROCHLORIDE
- **Generic name:** Doxorubicin Hydrochloride
- **Active ingredients:** DOXORUBICIN HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** HISUN PHARM HANGZHOU
- **First approval:** 2019-05-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206062)
---
*AI Analytics · CC0 1.0*